Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,409,867
-$4,432,834 QoQ
Shares Held
713,173
+93.8% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 334 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Sep 30, 2022CallValue
$2,674,500
CallShares
75,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. PRGO ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
201,159 | $108,993,980 | |
| 2 | HLN |
Haleon plc
|
9,264,255 | $86,435,499 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
629,806 | $69,870,677 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,250,639 | $51,313,718 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
659,493 | $42,174,577 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,059,778 | $35,905,278 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
2,235,821 | $11,022,597 | |
| 8 | EOLS |
Evolus, Inc.
|
1,508,518 | $10,469,114 |
All Filings in PRGO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,409,867 | 713,173 | Shares | Defined | 2026-08-14 | |
| 2024-03-31 | $11,842,701 | 367,900 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,579,162 | 390,900 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,987,612 | 750,786 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $6,180,517 | 181,300 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $2,674,500 | 75,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $65,197,178 | 1,828,300 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $59,147,003 | 1,457,900 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $30,766,010 | 790,900 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $105,673,691 | 2,232,700 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $116,518,605 | 2,541,300 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,474,601 | 1,197,791 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $6,018,801 | 131,100 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $17,848,949 | 322,941 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $19,120,487 | 397,598 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||